What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Cancer
Paolo Prandoni mostly deals with Surgery, Thrombosis, Venous thrombosis, Internal medicine and Deep vein.
His Surgery study combines topics from a wide range of disciplines, such as First episode and Risk factor.
His studies deal with areas such as Anticoagulant, Cancer, Vascular disease and Vein as well as Thrombosis.
His biological study spans a wide range of topics, including Odds ratio and Hazard ratio.
His work in Internal medicine addresses subjects such as Cardiology, which are connected to disciplines such as Case-control study.
His research in Deep vein intersects with topics in Radiology and Cumulative incidence.
His most cited work include:
- Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (5057 citations)
- COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS (3355 citations)
- The long-term clinical course of acute deep venous thrombosis. (1741 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Thrombosis, Surgery, Pulmonary embolism and Venous thrombosis.
In his research on the topic of Internal medicine, Stroke is strongly related with Cardiology.
His work is dedicated to discovering how Thrombosis, Radiology are connected with Plethysmograph and other disciplines.
The study incorporates disciplines such as First episode and Risk factor in addition to Surgery.
The concepts of his Pulmonary embolism study are interwoven with issues in Anesthesia, Rivaroxaban, Complication and Fondaparinux.
As a part of the same scientific family, Paolo Prandoni mostly works in the field of Venous thrombosis, focusing on Thrombophilia and, on occasion, Pediatrics.
He most often published in these fields:
- Internal medicine (47.18%)
- Thrombosis (42.36%)
- Surgery (42.03%)
What were the highlights of his more recent work (between 2014-2021)?
- Internal medicine (47.18%)
- Pulmonary embolism (29.07%)
- Thrombosis (42.36%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Pulmonary embolism, Thrombosis, Venous thromboembolism and Surgery.
His studies examine the connections between Internal medicine and genetics, as well as such issues in Cardiology, with regards to Stroke.
His research on Pulmonary embolism also deals with topics like
- Venous thrombosis that intertwine with fields like Myocardial infarction,
- Epidemiology most often made with reference to Prospective cohort study.
His Thrombosis study focuses on Deep vein in particular.
In his study, MEDLINE and Low molecular weight heparin is inextricably linked to Intensive care medicine, which falls within the broad field of Venous thromboembolism.
His Surgery research is multidisciplinary, incorporating elements of Cohort study and Cohort.
Between 2014 and 2021, his most popular works were:
- 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS) (626 citations)
- Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism (327 citations)
- 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) : The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC) (214 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Cancer
Paolo Prandoni spends much of his time researching Internal medicine, Pulmonary embolism, Thrombosis, Surgery and Venous thromboembolism.
His work in Internal medicine addresses issues such as Cardiology, which are connected to fields such as Ultrasonography and Peripheral.
His studies deal with areas such as Thrombolysis, Vitamin K antagonist, First episode, Rate ratio and Prospective cohort study as well as Pulmonary embolism.
He is involved in the study of Thrombosis that focuses on Deep vein in particular.
His work carried out in the field of Surgery brings together such families of science as Atrial fibrillation, Cohort study and Cohort.
His Venous thromboembolism research integrates issues from Diabetes mellitus, Cancer, Medical physics and Intensive care medicine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
